A
Price
$145.46
Change
-$1.95 (-1.32%)
Updated
Mar 28, 6:59 PM EST
53 days until earnings call
BRKR
Price
$93.94
Change
+$0.08 (+0.09%)
Updated
Mar 28, 6:59 PM EST
34 days until earnings call
Ad is loading...

A vs BRKR ᐉ Comparison: Which is Better to Invest?

Header iconA vs BRKR Comparison
Open Charts A vs BRKRBanner chart's image
Agilent Technologies
Price$145.46
Change-$1.95 (-1.32%)
Volume$424.94K
CapitalizationN/A
Bruker
Price$93.94
Change+$0.08 (+0.09%)
Volume$220.46K
CapitalizationN/A
View a ticker or compare two or three
A vs BRKR Comparison Chart

Loading...

ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
A vs. BRKR commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and BRKR is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (A: $145.51 vs. BRKR: $93.94)
Brand notoriety: A and BRKR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 129% vs. BRKR: 53%
Market capitalization -- A: $42.64B vs. BRKR: $12.93B
A [@Medical Specialties] is valued at $42.64B. BRKR’s [@Medical Specialties] market capitalization is $12.93B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green whileBRKR’s FA Score has 2 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • BRKR’s FA Score: 2 green, 3 red.
According to our system of comparison, A is a better buy in the long-term than BRKR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 6 TA indicator(s) are bullish while BRKR’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 6 bullish, 4 bearish.
  • BRKR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, A is a better buy in the short-term than BRKR.

Price Growth

A (@Medical Specialties) experienced а -2.17% price change this week, while BRKR (@Medical Specialties) price change was -0.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.84%. For the same industry, the average monthly price growth was -0.26%, and the average quarterly price growth was +4.27%.

Reported Earning Dates

A is expected to report earnings on May 21, 2024.

BRKR is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Medical Specialties (+0.84% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for A with price predictions.
OPEN
A.I.dvisor published
a Summary for BRKR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
A($42.6B) has a higher market cap than BRKR($12.9B). A has higher P/E ratio than BRKR: A (34.81) vs BRKR (32.39). BRKR YTD gains are higher at: 27.918 vs. A (4.661). A has higher annual earnings (EBITDA): 1.69B vs. BRKR (676M). A has more cash in the bank: 1.75B vs. BRKR (488M). BRKR has less debt than A: BRKR (1.38B) vs A (2.56B). A has higher revenues than BRKR: A (6.74B) vs BRKR (2.96B).
ABRKRA / BRKR
Capitalization42.6B12.9B330%
EBITDA1.69B676M250%
Gain YTD4.66127.91817%
P/E Ratio34.8132.39107%
Revenue6.74B2.96B227%
Total Cash1.75B488M358%
Total Debt2.56B1.38B185%
FUNDAMENTALS RATINGS
A vs BRKR: Fundamental Ratings
A
BRKR
OUTLOOK RATING
1..100
7681
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
3321
SMR RATING
1..100
4728
PRICE GROWTH RATING
1..100
2640
P/E GROWTH RATING
1..100
4878
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (21) in the Biotechnology industry is somewhat better than the same rating for BRKR (65) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than BRKR’s over the last 12 months.

BRKR's Profit vs Risk Rating (21) in the Medical Specialties industry is in the same range as A (33) in the Biotechnology industry. This means that BRKR’s stock grew similarly to A’s over the last 12 months.

BRKR's SMR Rating (28) in the Medical Specialties industry is in the same range as A (47) in the Biotechnology industry. This means that BRKR’s stock grew similarly to A’s over the last 12 months.

A's Price Growth Rating (26) in the Biotechnology industry is in the same range as BRKR (40) in the Medical Specialties industry. This means that A’s stock grew similarly to BRKR’s over the last 12 months.

A's P/E Growth Rating (48) in the Biotechnology industry is in the same range as BRKR (78) in the Medical Specialties industry. This means that A’s stock grew similarly to BRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABRKR
RSI
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
52%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
51%
Momentum
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 16 days ago
63%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Ad is loading...
ADaily Signal changed days agoGain/Loss if shorted
 
Show more...
BRKRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAR46.510.18
+0.39%
Darling Ingredients
TBPH8.96-0.05
-0.55%
Theravance Biopharma
SMTC27.49-0.37
-1.33%
Semtech Corp
AGNCL23.80-0.39
-1.61%
AGNC Investment Corp
ENLV3.79-0.07
-1.81%
Enlivex Therapeutics Ltd

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been loosely correlated with A. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BRKR jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
+0.09%
A - BRKR
62%
Loosely correlated
-1.26%
WAT - BRKR
60%
Loosely correlated
-0.28%
MTD - BRKR
55%
Loosely correlated
-0.34%
TMO - BRKR
51%
Loosely correlated
+0.32%
IQV - BRKR
50%
Loosely correlated
+0.13%
More